The Target ALS Global Natural History Study (GNHS) is entering a new phase of discovery. As the only international, ...
Today, we mourn the loss of Brooke Eby. Brooke was a powerhouse. Witty, clever, joyful, and direct. She was unwilling to be ...
Read on for updates across the Research we Enable Postmortem Tissue (PMT) Core The Target ALS Postmortem Core has now ...
Predicting Phenoconversion in Carriers of ALS Pathogenic Variants People carrying mutations known to cause ALS make up at ...
Invested in Biomarker Innovation ALS is a heterogeneous disease with distinct subpopulations of cases clustering together based on common underlying biology and with distinct differences in the ...
ALS (amyotrophic lateral sclerosis) is a disease that moves differently for everyone, but no one should have to face it ...
In 2011, Dr. Rosa Rademakers (VIB) and her team first identified the repeat expansion mutation in C9orf72 as a major genetic driver of ALS and FTD. However, since this breakthrough, scientists have ...
Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors. Guise AJ, Sellon MT, Roemer SF, Monine M, Comfort Harris NT, […] Plowey ED. JAMA Neurol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results